FDA NDC Directory · JSON-LD · Markdown

Duloxetine

NDC 67877-263 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA203197
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (20 mg/1)
Marketing started20120501
Package count5

External sources

Source: openFDA. Public-domain (CC0).